|
| 36563009 | Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. | Am J Physiol Heart Circ Physiol | 2023 |
| 37374057 | Stimulation of Angiotensin II Type 2 Receptor Modulates Pro-Inflammatory Response in Microglia and Macrophages: Therapeutic Implications for the Treatment of Stroke. | Life (Basel) | 2023 |
| 37065376 | Myocarditis as a Complication of Campylobacter jejuni-Associated Enterocolitis: A Report of Two Cases. | Cureus | 2023 |
| 35688299 | Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. | Neurochem Int | 2022 |
| 32875455 | Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis. | Transl Stroke Res | 2021 |
| 33572986 | Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. | Int J Mol Sci | 2021 |
| 34481068 | Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke. | Vascul Pharmacol | 2021 |
| 34831161 | Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis. | Cells | 2021 |
| 33954091 | Overview and Update on Methods for Cargo Loading into Extracellular Vesicles. | Processes (Basel) | 2021 |
| 32345303 | Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke. | J Neuroinflammation | 2020 |
| 31792796 | Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. | Transl Stroke Res | 2020 |
| 33214598 | Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats. | Sci Rep | 2020 |
| 29537907 | Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. | J Cereb Blood Flow Metab | 2019 |
| 30243988 | Post-stroke neovascularization and functional outcomes differ in diabetes depending on severity of injury and sex: Potential link to hemorrhagic transformation. | Exp Neurol | 2019 |
| 31315064 | Inflammation within the neurovascular unit: Focus on microglia for stroke injury and recovery. | Pharmacol Res | 2019 |
| 31098864 | Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA. | Drugs R D | 2019 |
| 30822121 | Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. | Am J Physiol Heart Circ Physiol | 2019 |
| 30818045 | NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. | Pharmacol Res | 2019 |
| 30816798 | Brain Vasculature and Cognition. | Arterioscler Thromb Vasc Biol | 2019 |
| 30296528 | Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals-A randomized double- blind pre-clinical study. | Behav Brain Res | 2019 |
| 28975464 | Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator. | Neurochem Res | 2018 |
| 38089216 | Medicine Pharmacy Interprofessional Exercise Pilot: Lessons Learned. | MedEdPublish (2016) | 2018 |
| 30103772 | RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. | J Neuroinflammation | 2018 |
| 30118341 | Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex. | Am J Physiol Heart Circ Physiol | 2018 |
| 30088238 | Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia. | Neurochem Res | 2018 |
| 29543776 | Within the Brain: The Renin Angiotensin System. | Int J Mol Sci | 2018 |
| 29229547 | Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study. | Behav Brain Res | 2018 |
| 26758277 | Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke. | Mol Neurobiol | 2017 |
| 28192099 | Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. | Eur J Pharmacol | 2017 |
| 28247188 | Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes. | Transl Stroke Res | 2017 |
| 28640888 | Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. | PLoS One | 2017 |
| 28887388 | Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial. | Stroke | 2017 |
| 26839355 | Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke. | Stroke | 2016 |
| 27482214 | ARBs improve stroke outcome through an AT2-dependent, BDNF-induced proangiogenic and prorecovery response. | Neural Regen Res | 2016 |
| 27303620 | Erratum to: Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke. | Exp Transl Stroke Med | 2016 |
| 27558234 | Nox4 contributes to the hypoxia-mediated regulation of actin cytoskeleton in cerebrovascular smooth muscle. | Life Sci | 2016 |
| 27127602 | Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke. | Exp Transl Stroke Med | 2016 |
| 26769658 | Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence. | Clin Sci (Lond) | 2016 |
| 27026092 | Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes. | Transl Stroke Res | 2016 |
| 24939693 | Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. | Mol Neurobiol | 2015 |
| 26317114 | Vascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure. | Receptors Clin Investig | 2015 |
| 26033700 | The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis. | Br J Pharmacol | 2015 |
| 26004281 | Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke. | Transl Stroke Res | 2015 |
| 25683354 | Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. | Transl Stroke Res | 2015 |
| 25754657 | Vascular protection with dipeptidyl peptidase-IV inhibitors in diabetes: experimental and clinical therapeutics. | Pharmacotherapy | 2015 |
| 25749094 | Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period. | Brain Res | 2015 |
| 25502293 | Erratum to: Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. | Mol Neurobiol | 2015 |
| 25420481 | Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1). | Angiogenesis | 2015 |
| 25552308 | SOD1 overexpression prevents acute hyperglycemia-induced cerebral myogenic dysfunction: relevance to contralateral hemisphere and stroke outcomes. | Am J Physiol Heart Circ Physiol | 2015 |
| 25524911 | Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes. | Diabetes | 2015 |